Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
If weight loss is your primary goal, the higher protocols are recommended
[4] The FDA label also provides guidance on when to consider discontinuation: if a patient has not lost at least 5% of their initial body weight after 12 weeks on the 2.4 mg dose, stopping treatment may be appropriate as further benefits are unlikely
it can be a signal that one of them is present
Lttl says it does not make medicine
US$ 28.54
US$ 22.08
US$ 21.51
